CClinicalTrials.gg
Enrolling by invitationNCT06679595PETRACAUpdated Nov 7, 2024

Transmural Care for Chronically Ill Children: Scientific Guidance and Evaluation of Pilot Projects

An observational study in Chronic Diseases in Children, Chronic Diseases in Adolescence and Health Personnel, sponsored by University Hospital, Ghent. Enrolling by invitation at 11 sites in Belgium. Per ClinicalTrials.gov, last updated 2024-11-07.

Sponsored by University Hospital, Ghent · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2026, 7 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
1,000
Sex
All
01

Study summary

The goal of this Realist Evaluation is to evaluate the implementation of pilot projects for transmural care in chronically ill children.

The main question it aims to answer is: To what extent and how do the pilot projects for transmural care for chronically ill children provide an answer to the quintuple aim?

Participants will

  • Complete questionnaires at three timepoints
  • Participate in focus group interviews
Read the detailed description

Introduction Chronic diseases have been increasing over the past few years, including in children. The chronic condition affects their daily functioning and quality of life and leads to frequent hospital admissions. To avoid unneccessary hospital admissions and to offer alternative and innovative forms of care, the Belgian Federal Public Service of Public Health, Food Chain Safety and Environment selected five pilot projects for transmural care for chronically ill children. This study was designed to evaluate these projects.

Methods and design The overall approach is a two-year longitudinal prospective Realist Evaluation using a mixed-methods design.

The quantitative strand, using routine data and questionnaires, will examine whether data from children, parents/legal guardians and healthcare professionals involved in a pilot project for paediatric transmural care comply with the quintuple aim outcomes.

The qualitative strand will be used (1) to evaluate the structure of the interventions, (2) for process evaluation and context analysis, and (3) to gather more in-depth information. This includes document analysis (including logbooks), focus groups with children, parents/legal guardians and healthcare professionals, and non-participatory observations.

Ethical Informed consent is required prior to inclusion in the evaluation study. Informed assent is requested from children older than 12 years. For this study, advice is asked from the Research Ethics Committee of Ghent University Hospital

02

Conditions studied

  • Chronic Diseases in Children
  • Chronic Diseases in Adolescence
  • Health Personnel
  • Parents

Browse trials for

Keywords

  • Realist Evaluation
  • Chronic Disease
  • Child
  • Adolescent
  • Infant
  • Home Care Services, Hospital-Based
03

In context

Chronic Disease

990 studies on the registry are indexed under Chronic Disease; 178 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 419 across 249 observational studies indexed under Chronic Disease.

Browse Chronic Disease studies →

Lead sponsor

University Hospital, Ghent is the lead sponsor of 665 studies on the registry; 156 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The setting of the study is defined as the five pilot projects for paediatric transmural care, conducted by Belgian acute care hospitals in collaboration with primary care. These projects focus on transfusions of concentrated red blood cells at home, ventilation of children with a respiratory disease at home, home enzyme therapy by infusion for children suffering from lysosomal metabolic disease and early discharge of neonates with (partial) tube feeding.

The study population consists of the people for whom the services offered by the pilot project are intended as defined in the implementation plan. This study population can be divided into four subgroups: the patients (children), their parents/legal guardians, healthcare professionals involved and the coordinators of the pilot projects.

Inclusion criteria

  • Children: any child up to the age of 18 participating in a pilot project for paediatric transmural care.
  • Parent/Legal guardian: any parent or legal guardian of a child participating in a pilot project for paediatric transmural care
  • Healthcare professionals: any healthcare professional with patient contact involved within a pilot project for paediatric transmural care
  • Coordinators: all study and care coordinators involved within a pilot project for paediatric transmural care

Exclusion criteria

Exclusion Criteria:

  • No signed informed consent form available
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Children

    Children up to the age of 18 with a chronic condition included in a pilot project for paediatric transmural care

    Other: Pilot project paediatric transmural care

  • Parents

    Parents/ legal guardians of children included in a pilot project for paediatric transmural care

    Other: Pilot project paediatric transmural care

  • Healthcare professionals

    Project coordinators and healtcare professionals involved in a pilot project for paediatric transmural care

    Other: Pilot project paediatric transmural care

Interventions

  • OtherPilot project paediatric transmural care

    The implementation of pilot projects for transmural care for chronically ill children

06

What researchers measure

Primary outcomes

  1. Quality of Life

    Quality of Life is used as an indicator for the aim "health status". The PedsQL (Paediatric Quality of Life Inventory) 4.0 Generic Core Scales is used to measure health-related quality of life in children and adolescents ages 2 to 18. The scale consists of 23 items and has a child self-report and parallel proxy-report format for ages 5-7, 8-12 and 13-18 years. The items are scored on a five-point Likert-scale, ranging from "never a problem" to "almost always a problem";.

    Time frame: Baseline, 6 months and through study completion, up to 18 months maximum.

  2. Parental Quality of Life

    Quality of Life is used as an indicator for the aim "health status". To estimate parent's quality of life, the take care tool (4 domains, 16 items) is used. The items are scored on a three-point Likert-scale, ranging from "Satisfied" to "Not satisfied".

    Time frame: Baseline, 6 months and through study completion, up to 18 months maximum.

  3. Caregiver burden

    Caregiver burden is used as an indicator for the aim "health status". The 4-item version of the Zarit Burden Interview is used to estimate the caregiver burden for the parents. The items are scored on a five-point Likert-scale, ranging from "Never" tot "Nearly Always"

    Time frame: Baseline, 6 months and through study completion, up to 18 months maximum.

  4. Diagnosis

    The diagnosis and date of diagnosis of the participant are collected as an indicator for the aim "health status". These data will be extracted from the (electronic) patient records.

    Time frame: Through study completion, up to 18 months maximum.

  5. Length of stay in the hospital

    The length of stay in the hospital, prior to the start of the transmural care of the participant are collected as an indicator for the aim "health status". These data will be extracted from the (electronic) patient records.

    Time frame: Through study completion, up to 18 months maximum.

  6. Length of stay in transmural care

    The length of stay in transmural care, measured by counting the total number of days each child receives this care, is an indicator for the aim "health status". These data will be extracted from the (electronic) patient records.

    Time frame: Through study completion, up to 18 months maximum.

  7. Transmural care at school

    If transmural care has been given at school, was evaluated as an indicator for the aim "health status". These data will be extracted from the (electronic) patient records.

    Time frame: Through study completion, up to 18 months maximum.

  8. Adverse events

    Adverse events are logged as an indicator for the aims "health status" and "quality of care". Adverse events are continuously logged by the project coordinators in a self-developed questionnaire.

    Time frame: Continuous data collection, until study completion (18 months)

  9. Patient experience

    Patient experience is used as an indicator for the aim "quality of care". Patient experience is measured among children (or by proxy under the age of 8) and among their parents. To avoid lengthy statements, a questionnaire was developed by the researchers for this purpose. The items are scored on a five-point Likert-scale, ranging from "Strongly disagree" to "Strongly agree".

    Time frame: Baseline, 6 months and through study completion, up to 18 months maximum.

  10. Parental Empowerment

    Parental empowerment is used as an indicator for the aim "quality of care". Patient empowerment is the patient's ability to have control over their health and their ability to be involved in care. In paediatrics, parents advocate strongly for what they feel is best for their child and family and want to feel they are able to make disicions. Therefore, the empowerment of parents is questioned. A questionnaire was developed by the researchers for this purpose. The items are scored on a five-point Likert-scale, ranging from "Strongly disagree" to "Strongly agree".

    Time frame: Baseline, 6 months and through study completion, up to 18 months maximum.

  11. Job Satisfaction

    Job Satisfaction is used as an indicator for the aim "value healthcare professionals". The Michigan Organizational Assessment Questionnaire Job Satisfaction Subscale (MOAQ-JSS) is used to measure job satisfaction among the healthcare professionals involved. The three items are scored on a five-point Likert-scale, ranging from "Strongly disagree" to "Strongly agree".

    Time frame: Baseline, 6 months and through study completion, up to 18 months maximum.

  12. Work-related stress

    Work-related stress is used as an indicator for the aim "value healthcare professionals". Work-related stress is measured using a single question developed by the researchers. The item is scored on a five-point Likert-scale, ranging from "Strongly disagree" to "Strongly agree".

    Time frame: Baseline, 6 months and through study completion, up to 18 months maximum .

  13. Quality of Work

    Quality of Work is used as an indicator for the aim "value healthcare professionals". The dimension Quality of Work of the COPSOQ II is used to measure the experience by the healthcare professional of the immediate output of work. The two items are scored on a five-point Likert-scale, ranging from "To a very large extent" to "To a very small extent".

    Time frame: Baseline, 6 months and through study completion, up to 18 months maximum.

  14. Competence and Training

    Competence and Training is used as an indicator for the aim "value healthcare professionals". It is important that the healthcare professional providing care at home with children has solid paediatric competencies and experience. Competence and training are questioned among healthcare professionals, using a self-developed questionnaire.

    Time frame: Baseline, 6 months and through study completion, up to 18 months maximum.

  15. Socio-demographic variables

    Socio-demographic variables are used as an indicator for the aim "equity and inclusion". These variables are questioned among parents and healthcare professionals.

    Time frame: Baseline, 6 months and through study completion, up to 18 months maximum.

  16. Socio-economic variables

    Socio-economic variables are used as an indicator for the aim "equity and inclusion". Financial status, education, employment status and productivity loss based on the iCPQ are questioned among parents.

    Time frame: Baseline, 6 months and through study completion, up to 18 months maximum.

07

Study locations

11 sites
  • Hôpital universitaire des enfants Reine Fabiola
    Bruxelles, 1020, Belgium
  • Cliniques Universitaires Saint-Luc
    Bruxelles, 1200, Belgium
  • Institut de Pathologie et de Génétique Charleroi
    Charleroi, 6041, Belgium
  • University Hospital Antwerp
    Edegem, 2650, Belgium
  • Universitair Ziekenhuis Gent
    Gent, 9000, Belgium
  • Universitair Ziekenhuis Brussel
    Jette, 1090, Belgium
  • Centre Hospitalier Jolimont-Lobbes
    La Louvière, 7100, Belgium
  • Universitaire Ziekenhuizen Leuven
    Leuven, 3000, Belgium
  • Centre Hospitalier Régional de la Citadelle
    Liège, 4000, Belgium
  • Centre Hospitaliere Universitaire de Liège
    Liège, 4000, Belgium
  • Clinique CHC MontLégia
    Liège, 4000, Belgium
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06679595
Lead sponsor
University Hospital, Ghent
Collaborators
Centre Hospitalier Regional de la Citadelle, Centre Hospitalier Jolimont-Lobbes, University Hospital, Antwerp, Universitaire Ziekenhuizen KU Leuven, Centre Hospitalier Universitaire de Liege, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Universitair Ziekenhuis Brussel, Institut de Pathologie et de Génétique Charleroi, CHC Montlegia, Hôpital universitaire des enfant Reine Fabiola
Responsible party
Sponsor
First posted
Nov 7, 2024
Start date
Sep 10, 2024
Primary completion
Feb 28, 2026 (estimated)
Completion
Feb 28, 2026 (estimated)
Last update
Nov 7, 2024

Study contacts

Sabine Van daele, Prof. dr.
principal investigator · University Hospital, Ghent
Veerle Duprez, dr.
principal investigator · University Hospital, Ghent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion